CN Patent

CN103396398A — 激肽原1受体拮抗剂

Assigned to Janssen Pharmaceutica NV · Expires 2013-11-20 · 12y expired

What this patent protects

本发明涉及某些新的式(I)化合物、制备这些化合物及其组合物、中间体和衍生物的方法和治疗激肽原1或prokinetin 1受体介导的病症的方法。

USPTO Abstract

本发明涉及某些新的式(I)化合物、制备这些化合物及其组合物、中间体和衍生物的方法和治疗激肽原1或prokinetin 1受体介导的病症的方法。

Drugs covered by this patent

Patent Metadata

Patent number: CN103396398A
Jurisdiction: CN
Classification: —
Expires: 2013-11-20
Drug substance claim: No
Drug product claim: No
Assignee: Janssen Pharmaceutica NV
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.